The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Early Diagnosis of Cystic Fibrosis Through Neonatal Screening Prevents Severe Malnutrition and Improves Long-Term Growth
Abstract
Objective.: Despite its relative frequency among autosomal recessive diseases and the availability of the sweat test, cystic fibrosis (CF) has been difficult to diagnose in early childhood, and delays can lead to severe malnutrition, lung disease, or even death. The Wisconsin CF Neonatal Screening Project was designed as a randomized clinical trial to assess the benefits and risks of early diagnosis through screening. In addition, the incidence of CF was determined, and the validity of our randomization method assessed by comparing 16 demographic variables. Methodology.: Immunoreactive trypsinogen analysis was applied to dried newborn blood specimens for recognition of CF risk from 1985 to 1991 and was coupled to DNA-based detection of the ΔF508 mutation from 1991 to 1994. Randomization of 650 341 newborns occurred when their blood specimens reached the Wisconsin screening laboratory. This created 2 groups—an early diagnosis, screened cohort and a standard diagnosis or control group. To avoid selection bias, we devised a unique unblinding method with a surveillance program to completely identify the control subjects. Because sequential analysis of nutritional outcome measures revealed significantly better growth in screened patients during 1996, we accelerated the unblinding and completely identified the control group by April 1998. Having each member of this cohort enrolled and evaluated for at least 1 year and having completed a comprehensive surveillance program, we performed another statistical analysis of anthropometric evaluated indices that includes all CF patients without meconium ileus. Results.: The incidence of classical CF, ie, patients diagnosed in this trial with a sweat chloride of 60 mEq/L greater, was 1:4189. By incorporating other CF patients born during the randomization period, including 2 autopsy diagnosed patients and 8 probable patients, we calculate a maximum incidence of 1:3938 (95% confidence interval: 3402–4611). Although there were group differences in the proportion of patients with ΔF508 genotypes and with pancreatic insufficiency, validity of the randomization plan was demonstrated by analyzing 16 demographic variables and finding no significant difference after adjustment for multiple comparisons. Focusing on patients without meconium ileus, we found a marked difference in the mean ± standard deviation age of diagnosis for screened patients (13 ± 37 weeks), compared with the standard diagnosis group (100 ± 117). Anthropometric indices of nutritional status were significantly higher at diagnosis in the screened group, including length/height, weight, and head circumference. During 13 years of study, despite similar nutritional therapy and the inherently better pancreatic status of the control group, analysis of nutritional outcomes revealed significantly greater growth associated with early diagnosis. Most impressively, the screened group had a much lower proportion of patients with weight and height data below the 10th percentile throughout childhood. Conclusions.: Although the screened group had a higher proportion of patients with pancreatic insufficiency, their growth indices were significantly better than those of the control group during the 13-year follow-up evaluation and, therefore, this randomized clinical trial of early CF diagnosis must be interpreted as unequivocally positive. Our conclusions did not change when the height and weight data before 4 years of age for the controls detected by unblinding were included in the analysis. Also, comparison of growth outcomes after 4 years of age in all subjects showed persistence of the significant differences. Therefore, selection bias has been eliminated as a potential explanation. In addition, the results show that severe malnutrition persists after delayed diagnosis of CF and that catch-up may not be possible. We conclude that early diagnosis of CF through neonatal screening combined with aggressive nutritional therapy can result in significantly enhanced long-term nutritional status.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Longitudinal data analysis using generalized linear models
LIANG, K.-Y., & ZEGER, S. L. (1986) · Biometrika · doi:10.1093/biomet/73.1.13 · Cited by 18,550
Physical growth: National Center for Health Statistics percentiles
Hamill, P. V. V., Drizd, T., Johnson, C., Reed, R., Roche, A., & Moore, W. (1979) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/32.3.607 · Cited by 2,323
SHWACHMAN, H. (1958) · A.M.A. Journal of Diseases of Children · doi:10.1001/archpedi.1958.02060060008002 · Cited by 994
Prediction of mortality in patients with cystic fibrosis
Kerem, E., Reisman, J., Corey, M., Canny, G. J., & Levison, H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204303261804 · Cited by 993
Kerem, E., Corey, M., Kerem, B.-S., Rommens, J., Markiewicz, D., Levison, H., Tsui, L.-C., & Durie, P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011293232203 · Cited by 728
Nutritional assessment and management in cystic fibrosis: a consensus report
Ramsey, B., Farrell, P., & Pencharz, P. (1992) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/55.1.108 · Cited by 411
Self-citationNutritional Benefits of Neonatal Screening for Cystic Fibrosis
Farrell, P. M., Kosorok, M. R., Laxova, A., Shen, G., Koscik, R. E., Bruns, W. T., Splaingard, M., & Mischler, E. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710023371403 · Cited by 388
Self-citationRELATIVE UNDERWEIGHT IN CYSTIC FIBROSIS AND ITS PROGNOSTIC VALUE
KRAEMER, R., RÜDEBERG, A., HADORN, B., & ROSSI, E. (1978) · Acta Paediatrica · doi:10.1111/j.1651-2227.1978.tb16273.x · Cited by 308
Incidence, population, and survival of cystic fibrosis in the UK, 1968-95
Dodge, J. A., Morison, S., Lewis, P. A., Coles, E. C., Geddes, D., Russell, G., Littlewood, J. M., & Scott, M. T. (1997) · Archives of Disease in Childhood · doi:10.1136/adc.77.6.493 · Cited by 252
Efficacy of Statewide Neonatal Screening for Cystic Fibrosis by Assay of Trypsinogen Concentrations
Hammond, K. B., Abman, S. H., Sokol, R. J., & Accurso, F. J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109123251104 · Cited by 179
Lai, H.-C., Kosorok, M. R., Sondel, S. A., Chen, S.-T., FitzSimmons, S. C., Green, C. G., Shen, G., Walker, S., & Farrell, P. M. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70024-1 · Cited by 178
Self-citationNewborn screening for cystic fibrosis
Southern, K. W., Mérelle, M. M. E., Dankert-Roelse, J. E., & Nagelkerke, A. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001402.pub2 · Cited by 168
Wilcken, B., Wiley, V., Sherry, G., & Bayliss, U. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70040-4 · Cited by 163
Chatfield, S., Owen, G., Ryley, H. C., Williams, J., Alfaham, M., Goodchild, M. C., & Weller, P. (1991) · Archives of Disease in Childhood · doi:10.1136/adc.66.1_spec_no.29 · Cited by 158
Clinical outcomes of newborn screening for cystic fibrosis
Waters, D., Wilcken, B. M., Irwig, L., Asperen, P. V., Mellis, C., Simpson, J. M., Brown, J., & Gaskin, K. J. (1999) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/fn.80.1.f1 · Cited by 156
Dankert-Roelse, J. E., & Meerman, G. J. T. (1995) · Thorax · doi:10.1136/thx.50.7.712 · Cited by 142
Assessing the Effectiveness of Community Screening Programs
Cadman, D. T. (1984) · JAMA · doi:10.1001/jama.1984.03340360046028 · Cited by 139
Newborn Screening for Cystic Fibrosis in Wisconsin: Comparison of Biochemical and Molecular Methods
Gregg, R. G., Simantel, A., Farrell, P. M., Koscik, R. E., Kosorok, M. R., Laxova, A., Laessig, R. H., Hoffman, G. L., Hassemer, D. J., Mischler, E. H., et al. (1997) · PEDIATRICS · doi:10.1542/peds.99.6.819 · Cited by 137
Self-citationTHE INCIDENCE OF CYSTIC FIBROSIS
Kosorok, M. R., WEI, W.-H., & Farrell, P. M. (1996) · Statistics in Medicine · Cited by 132
Self-citationSweat Chloride Concentrations in Infants Homozygous or Heterozygous for F508 Cystic Fibrosis
Farrell, P. M., & Koscik, R. E. (1996) · PEDIATRICS · doi:10.1542/peds.97.4.524 · Cited by 129
Self-citationGregg, R. G., Wilfond, B. S., Farrell, P. M., et al. (1993) · PubMed · Cited by 128
Self-citationLai, H.-C., Kosorok, M. R., Laxova, A., et al. (2000) · PEDIATRICS · doi:10.1542/peds.105.1.53 · Cited by 122
Self-citationNutritional status of infants with cystic fibrosis associated with early diagnosis and intervention
Marcus, M., Sondel, S., Farrell, P., et al. (1991) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/54.3.578 · Cited by 112
Self-citationImproving the Health of Patients With Cystic Fibrosis Through Newborn Screening
Farrell, P. M. (2000) · Advances in Pediatrics · doi:10.1016/s0065-3101(23)00095-6 · Cited by 104
Self-citationEffect of linoleic acid intake on growth of infants with cystic fibrosis
van Egmond, A., Kosorok, M., Koscik, R. E., Laxova, A., & Farrell, P. (1996) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/63.5.746 · Cited by 89
Self-citationFarrell, P. M. (2000) · PubMed · Cited by 89
Self-citationNewborn Screening for Cystic Fibrosis
Farrell, P. M., & Mischler, E. H. (1992) · Advances in Pediatrics · doi:10.1016/s0065-3101(24)00279-2 · Cited by 79
Self-citationFost, N., & Pm, F. (1989) · PubMed · Cited by 72
Newborn screening for cystic fibrosis: Its evolution and a review of the current situation
Wilcken, B. M. (1993) · Screening · doi:10.1016/0925-6164(93)90017-d · Cited by 68
Neonatal screening for cystic fibrosis
Wald, N. J., & Morris, J. K. (1998) · BMJ · doi:10.1136/bmj.316.7129.404 · Cited by 51
Newborn screening for cystic fibrosis. The Cystic Fibrosis Neonatal Screening Study Group.
Pm, F., & Eh, M. (1992) · PubMed · Cited by 43
Predigested formula for infants with cystic fibrosis
Farrell, P. M., Mischler, E. H., Sondel, S. A., & Palta, M. (1987) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(21)03321-6 · Cited by 34
Self-citationAdvances in the diagnosis and management of cystic fibrosis
Blythe, S. A., & Farrell, P. M. (1984) · Clinical Biochemistry · doi:10.1016/s0009-9120(84)90541-1 · Cited by 26
Self-citationDisproportionate head growth retardation in cystic fibrosis.
Ghosal, S., Taylor, C., Pickering, M. C., et al. (1995) · Archives of Disease in Childhood · doi:10.1136/adc.72.2.150 · Cited by 13
Cited by
O'Sullivan, B. P., & Freedman, S. D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60327-5 · Cited by 1,320
The future of cystic fibrosis care: a global perspective
Bell, S. C., Mall, M. A., Gutierrez, H., Macek, M., Madge, S., Davies, J. C., Burgel, P.-R., Tullis, E., Castaños, C., Castellani, C., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30337-6 · Cited by 974
Self-citationRatjen, F., & Döring, G. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12567-6 · Cited by 885
Upton, P., Lawford, J., & Eiser, C. (2008) · Quality of Life Research · doi:10.1007/s11136-008-9350-5 · Cited by 774
Screening Newborns for Inborn Errors of Metabolism by Tandem Mass Spectrometry
Wilcken, B., Wiley, V., Hammond, J., & Carpenter, K. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025225 · Cited by 677
Metadata
- Authors
- Farrell, P. M., Kosorok, M. R., Rock, M. J., Laxova, A., Zeng, L., Lai, H.-C., Hoffman, G., Laessig, R. H., Splaingard, M. L., & the Wisconsin Cystic Fibrosis Neonatal Screening Study Group
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2001-01-01
- Volume
- 107
- Issue
- 1
- Pages
- 1-13
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2126809978
- Cited by
- 837
- References
- 34
- FWCI
- 46.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.